NHS must accelerate use of weight-loss jabs, say obesity experts

Trials have shown weight-loss jabs can reduce the risk of the onset of 42 conditions, among them cancer and cardiovascular disease. Photograph: Barry Diomede/Alamy

The NHS must accelerate its use of weight loss jabs, experts have said, as society enters a “golden age” of such medications.

Obesity is linked to numerous long-term conditions including cancer, heart disease, dementia and diabetes, putting a huge strain on the NHS.